Endologix has been granted a patent for a stent featuring a helical main body composed of rings with skewed v-shaped elements. The design includes end rings and transitional regions that connect these components, incorporating unique gaps and apex configurations to enhance functionality. GlobalData’s report on Endologix gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Endologix, Prosthetic cardiac valves was a key innovation area identified from patents. Endologix's grant share as of July 2024 was 51%. Grant share is based on the ratio of number of grants to total number of patents.
Helical stent with skewed v-shaped elements and transition regions
The patent US12070400B2 describes a stent design characterized by a main body composed of multiple rings arranged in a helical structure. Each ring features skewed v-shaped elements, which include a first leg and a longer second leg. The design incorporates an end ring with a unique configuration of apices and a transition region that connects the end ring to the main body. This transition region is defined by a series of struts linking corresponding apices of the end ring and the adjacent ring, with specific gaps between certain apices that vary in length. Additionally, the end ring may include tear drop shaped elements, enhancing the stent's structural integrity and functionality.
Further claims detail the relationships between the struts, including variations in their lengths and distances between them, which are designed to optimize the stent's performance. The stent also features multiple connecting struts that link adjacent rings, with specific arrangements that ensure stability and flexibility. The design allows for a second end ring positioned opposite the first, with both end rings oriented at angles relative to the main body. This innovative stent structure aims to improve vascular support and adaptability within the body, potentially enhancing patient outcomes in medical applications.
To know more about GlobalData’s detailed insights on Endologix, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
